Open Access Repository

Does isoniazid preventive therapy provide better treatment outcomes in HIV-infected individuals in Northern Ethiopia? A retrospective cohort study

Downloads

Downloads per month over past year

Atey, TM, Bitew, H, Asgedom, SW, Endrias, A and Berhe, DF 2020 , 'Does isoniazid preventive therapy provide better treatment outcomes in HIV-infected individuals in Northern Ethiopia? A retrospective cohort study' , AIDS Research and Treatment , pp. 1-11 , doi: 10.1155/2020/7025738.

[img] PDF (Published version)
145977 - does i...pdf | Download (2MB)

Abstract

Objectives: Early antiretroviral therapy (ART), isoniazid preventive therapy (IPT), and isoniazid-rifapentine (3HP) are effective strategies for preventing tuberculosis (TB) among people living with HIV (PLHIV). The study aimed to determine the effect of IPT on the TB incidence, follow-up CD4+ T cells, and all-cause mortality rate. Participants: Eligible patients on ART (n = 1, 863) were categorized into one-to-two ratios of exposed groups to IPT (n = 621) and nonexposed groups to IPT (n = 1, 242). Exposed groups entered the cohort at their first prescription of IPT, and unexposed groups entered into the study at the first prescription of ART and then followed until the occurrence of the outcome or date of administrative censoring (June 30, 2017). The outcome endpoints were TB incidence, follow-up CD4+ T cells, and all-cause mortality rate. Results: The follow-up CD4+ T cells for the exposed and nonexposed groups were 405.74 and 366.95 cells/mm (World Health Organization (WHO), 2017), respectively, a statistically significant finding (t1861 = −3.770, , p d = 0.186). Nine percent of the exposed patients (620 incidence of TB per 100,000 person-years (PYs)) and 21.9% of the nonexposed patients (3160 incidence of TB per 100,000 PYs) developed TB. Mortality rate (per 100,000 PYs) was 440 for the exposed and 1490 for the unexposed patients. Statistically significant determinants of the all-cause mortality were unscheduled follow-up (AHR = 1.601; 95% CI: 1.154–2.222) and unable to work properly (AHR = 2.324; 95% CI: 1.643–3.288). Conclusion: This study demonstrates the effect of IPT in reducing incidence of TB and all-cause mortality rate and improving follow-up CD4+ T cells. Promoting IPT use can help to achieve the TB eradicating national agenda in Ethiopia.

Item Type: Article
Authors/Creators:Atey, TM and Bitew, H and Asgedom, SW and Endrias, A and Berhe, DF
Keywords: pharmacy, clinical pharmacy, pharmacy practice
Journal or Publication Title: AIDS Research and Treatment
Publisher: Hindawi Publishing Corporation
ISSN: 2090-1240
DOI / ID Number: 10.1155/2020/7025738
Copyright Information:

Copyright © 2020 Tesfay Mehari Atey et al. ,is is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License, (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP